• Profile
Close

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Gynecologic Oncology Mar 09, 2020

Beavis AL, Yen TT, Stone RL, et al. - In this multi-institutional, retrospective cohort study, researchers contrasted the survival of women with early-stage endometrioid endometrial cancer (EEC) with lymphovascular space invasion (LVSI) treated postoperatively with observation (OBS), radiation (RAD, external beam and/or vaginal brachytherapy), or chemotherapy (CHEMO)+/−RAD. The sample consisted of women (n = 478), the median age was 64 years, with stage I or II EEC with LVSI who had hysterectomy+/−lymphadenectomy from 2005 to 2015 and received OBS, RAD, or CHEMO+/−RAD postoperatively. According to findings, adjuvant therapy improved PFS vs observation alone in early-stage EEC with LVSI. Adjuvant chemotherapy with or without radiation improved PFS vs observation or radiation alone in those with grade 3 EEC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay